Last update 17 Apr 2025

Imalumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-MIF monoclonal antibody, Immunoglobulin g1-kappa, anti-(homo sapiens mif (macrophage migration inhibitory factor, glycosylation-inhibiting factor, glif, gif)), homo sapiens monoclonal antibody, BAX-069
+ [1]
Target
Action
inhibitors, modulators
Mechanism
MIF inhibitors(Macrophage migration inhibitory factor inhibitors), Immunomodulators
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
-Imalumab-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Malignant ascitesPhase 2
United States
02 Nov 2015
Refractory Ovarian CarcinomaPhase 2
United States
02 Nov 2015
Metastatic Colorectal CarcinomaPhase 2
United States
15 Jun 2015
AscitesPhase 2--
Colorectal CancerPhase 2--
Lupus NephritisPhase 1
United States
28 Nov 2011
Lupus NephritisPhase 1
Australia
28 Nov 2011
Lupus NephritisPhase 1
Canada
28 Nov 2011
Lupus NephritisPhase 1
Mexico
28 Nov 2011
Lupus NephritisPhase 1
New Zealand
28 Nov 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
2
(Single-Route Arm)
huynmpxhpa = cwahawqhuw uacsrwfemt (qqmwjsfotm, oolqfbgopc - vfwmtoafbn)
-
15 Jun 2017
(Double-Route Arm)
huynmpxhpa = ysdztsckpz uacsrwfemt (qqmwjsfotm, ckkvykwbdc - klstkaajah)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free